BIO Green Papers To Issue Rights Shares, Key Dates & Details Revealed

BIO Green Papers To Issue Rights Shares, Key Dates & Details Revealed

BIO Green Papers Limited announces a rights issue of 67 shares for every 83 held, at Rs 52 per share. The record date is April 4, 2025, with ex-rights trading starting the same day.

Manoj YadavUpdated: Wednesday, April 02, 2025, 12:59 PM IST
article-image
BIO Green Papers Limited Announces Rights Issue, Record Date Fixed |

Mumbai: BIO Green Papers Limited (Company Code: 534535) has announced a rights issue of equity shares. This means existing shareholders can buy additional shares at a special price. The company will issue 67 equity shares of Rs 10 each, at a premium of Rs 42 per share.

Eligibility and Record Date

The record date for this rights issue is set for April 4, 2025. Shareholders holding shares as of this date will be eligible to participate. The rights issue will be on the basis of 67 new shares for every 83 existing shares held.

Ex-Rights Trading Information

Trading in BIO Green Papers shares will be on an ex-rights basis starting from April 4, 2025, under settlement number DR-605/2025-2026. This means shares bought after this date will not be eligible for the rights issue.

Payment Details

The issue price of Rs 52 per share (Rs 10 face value + Rs 42 premium) is payable at the time of application.

RECENT STORIES

Dentsu Lays Off 3,400 Employees Globally Amid Cost-Cutting Drive

Dentsu Lays Off 3,400 Employees Globally Amid Cost-Cutting Drive

Nazara Tech Shares Slide 20% In 4 Days Amid Online Gaming Bill Concerns

Nazara Tech Shares Slide 20% In 4 Days Amid Online Gaming Bill Concerns

IREDA Signs MoU With MNRE, Sets ₹8,200 Crore Revenue Target For FY 2025-26

IREDA Signs MoU With MNRE, Sets ₹8,200 Crore Revenue Target For FY 2025-26

Gold Slips ₹200 To ₹1,00,170 Per 10 Grams; Silver Trades Flat At ₹1,15,000 Per kg

Gold Slips ₹200 To ₹1,00,170 Per 10 Grams; Silver Trades Flat At ₹1,15,000 Per kg

GST Council's decision To Slash GST On Cancer Medicines, Essential Drugs ‘Commendable’: IMA

GST Council's decision To Slash GST On Cancer Medicines, Essential Drugs ‘Commendable’: IMA